Garrett Winslow
General Counsel, F-star Therapeutics, Inc.
Companies
- Damora Therapeutics, Inc.General counsel May 11, 2021 to now1
- F-star Therapeutics, Inc.General counsel Mar 9, 2020 to Nov 23, 20202
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Damora Therapeutics, Inc. DMRA2,289 shares3$41.9K at $18.32Jul 6, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 6, 2026Sold 245 shares at $29.98 of Damora Therapeutics, Inc.3
- Jul 3, 2026Exercised options 680 shares of Damora Therapeutics, Inc.3
- Jan 2, 2026Sold 255 shares at $21.38 of Damora Therapeutics, Inc.4
- Jan 2, 2026Exercised options 680 shares of Damora Therapeutics, Inc.4
- Jul 3, 2025Sold 260 shares at $3.39 of Damora Therapeutics, Inc.5
- Jul 3, 2025Exercised options 680 shares of Damora Therapeutics, Inc.5
- Jan 3, 2025Sold 471 shares at $5.60 of Damora Therapeutics, Inc.6
- Jan 3, 2025Exercised options 1,320 shares of Damora Therapeutics, Inc.6
- Dec 3, 2021Bought 2,000 shares at $2.48 of Damora Therapeutics, Inc.7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed Jan 6, 2026
- 5SEC EDGARForm 4 filed Jul 8, 2025
- 6SEC EDGARForm 4 filed Jan 7, 2025
- 7SEC EDGARForm 4 filed Dec 6, 2021